Cervical Cancer

Anal Cancer

Anogenital Warts

Non-Genital Warts

EBV Infection in Transplant Recipients

CMV Infection in Transplant Recipients

Notice: We do not have approval from the U.S. Food and Drug Administration or any other governmental agency, whether in the U.S. or abroad, to sell or market any product to treat or cure any disease or condition, including our drug candidates that we hypothesize may, following further study, clinical trials and all required approvals, be used to treat diseases associated with Human Papillomavirus (“HPV”), Cytomegalovirus (“CMV”), Hepatitis B (“HBV”), Herpes Simplex Virus (“HSV”), Epstein-Barr Virus (“EBV”), or Varicella Zoster Virus (“VZV”), including but not limited to Cervical Cancer, Anal Cancer, Skin and Genital Warts, or EBV and CMV Infection in Transplant Recipients. Our drug candidates have not completed the approval process (including, but not limited to clinical trials) that is required by the U.S. Food and Drug Administration. Our drug candidates have not been proven safe and effective and may not receive U.S. Food and Drug Administration approval. We do not currently sell any drug products or other treatments.